Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 172 | 0 | 0 |
| Gross Profit | N/A | N/A | 172 | N/A | N/A |
| Operating Expenses | 7,257 | 10,505 | 12,185 | 15,985 | 11,799 |
| Operating Income | -7,257 | -10,505 | -12,013 | -14,957 | -11,799 |
| Interest Expense | 725 | 877 | 943 | 1,126 | 1,337 |
| Other Income | 68 | 158 | 218 | 361 | 414 |
| Pre-tax Income | -7,914 | -11,224 | -12,738 | -15,722 | -12,722 |
| Net Income Continuous | -7,914 | -11,224 | -12,738 | -15,722 | -12,722 |
| Minority Interests | -2,502 | -4,532 | -5,474 | -6,775 | -5,939 |
| Net Income | $-5,412 | $-6,692 | $-7,264 | $-8,947 | $-6,783 |
| EPS Basic Total Ops | -0.12 | -0.18 | -0.22 | -0.26 | -0.24 |
| EPS Basic Continuous Ops | -0.17 | -0.31 | -0.38 | -0.47 | -0.44 |
| EPS Diluted Total Ops | -0.12 | -0.18 | -0.22 | -0.26 | -0.24 |
| EPS Diluted Continuous Ops | -0.17 | -0.31 | -0.38 | -0.47 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.18 | -0.22 | -0.27 | -0.24 |
| EBITDA(a) | $-6,976 | $-10,215 | $-11,854 | $-15,968 | $-11,792 |